BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 27194473)

  • 21. Protein kinase C epsilon mediates the inhibition of angiotensin II on the slowly activating delayed-rectifier potassium current through channel phosphorylation.
    Gou X; Wang W; Zou S; Qi Y; Xu Y
    J Mol Cell Cardiol; 2018 Mar; 116():165-174. PubMed ID: 29452158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Engineering a peptide inhibitor towards the KCNQ1/KCNE1 potassium channel (IKs).
    Hu Y; Chen J; Wang B; Yang W; Zhang C; Hu J; Xie Z; Cao Z; Li W; Wu Y; Chen Z
    Peptides; 2015 Sep; 71():77-83. PubMed ID: 26188173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery, synthesis and biological evaluation of 2-(4-(N-phenethylsulfamoyl)phenoxy)acetamides (SAPAs) as novel sphingomyelin synthase 1 inhibitors.
    Li YL; Qi XY; Jiang H; Deng XD; Dong YP; Ding TB; Zhou L; Men P; Chu Y; Wang RX; Jiang XC; Ye DY
    Bioorg Med Chem; 2015 Sep; 23(18):6173-84. PubMed ID: 26314925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. KCNE1 and KCNE3 stabilize and/or slow voltage sensing S4 segment of KCNQ1 channel.
    Nakajo K; Kubo Y
    J Gen Physiol; 2007 Sep; 130(3):269-81. PubMed ID: 17698596
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ginsenoside Rg3 activates human KCNQ1 K+ channel currents through interacting with the K318 and V319 residues: a role of KCNE1 subunit.
    Choi SH; Shin TJ; Lee BH; Chu DH; Choe H; Pyo MK; Hwang SH; Kim BR; Lee SM; Lee JH; Kim DH; Kim HC; Rhim HW; Nah SY
    Eur J Pharmacol; 2010 Jul; 637(1-3):138-47. PubMed ID: 20399767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKCβII specifically regulates KCNQ1/KCNE1 channel membrane localization.
    Braun C; Parks XX; Qudsi H; Lopes CM
    J Mol Cell Cardiol; 2020 Jan; 138():283-290. PubMed ID: 31785237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. KCNQ1 rescues TMC1 plasma membrane expression but not mechanosensitive channel activity.
    Harkcom WT; Papanikolaou M; Kanda V; Crump SM; Abbott GW
    J Cell Physiol; 2019 Aug; 234(8):13361-13369. PubMed ID: 30613966
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Steric hindrance between S4 and S5 of the KCNQ1/KCNE1 channel hampers pore opening.
    Nakajo K; Kubo Y
    Nat Commun; 2014 Jun; 5():4100. PubMed ID: 24920132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A conserved arginine/lysine-based motif promotes ER export of KCNE1 and KCNE2 to regulate KCNQ1 channel activity.
    Hu B; Zeng WP; Li X; Al-Sheikh U; Chen SY; Ding J
    Channels (Austin); 2019 Dec; 13(1):483-497. PubMed ID: 31679457
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KCNE1 and KCNE3 modulate KCNQ1 channels by affecting different gating transitions.
    Barro-Soria R; Ramentol R; Liin SI; Perez ME; Kass RS; Larsson HP
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7367-E7376. PubMed ID: 28808020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of KCNQ1/KCNE1 by β-catenin.
    Wilmes J; Haddad-Tóvolli R; Alesutan I; Munoz C; Sopjani M; Pelzl L; Bogatikov E; Fedele G; Faggio C; Seebohm G; Föller M; Lang F
    Mol Membr Biol; 2012; 29(3-4):87-94. PubMed ID: 22583083
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of sphingomyelin synthase-1 but not sphingomyelin synthase-2 causes hearing impairments in mice.
    Lu MH; Takemoto M; Watanabe K; Luo H; Nishimura M; Yano M; Tomimoto H; Okazaki T; Oike Y; Song WJ
    J Physiol; 2012 Aug; 590(16):4029-44. PubMed ID: 22641779
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct observation of individual KCNQ1 potassium channels reveals their distinctive diffusive behavior.
    Mashanov GI; Nobles M; Harmer SC; Molloy JE; Tinker A
    J Biol Chem; 2010 Feb; 285(6):3664-3675. PubMed ID: 19940153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stoichiometry of the KCNQ1 - KCNE1 ion channel complex.
    Nakajo K; Ulbrich MH; Kubo Y; Isacoff EY
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18862-7. PubMed ID: 20962273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of disease pathogenesis in long QT syndrome type 5.
    Harmer SC; Wilson AJ; Aldridge R; Tinker A
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C263-73. PubMed ID: 19907016
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A590T mutation in KCNQ1 C-terminal helix D decreases IKs channel trafficking and function but not Yotiao interaction.
    Kinoshita K; Komatsu T; Nishide K; Hata Y; Hisajima N; Takahashi H; Kimoto K; Aonuma K; Tsushima E; Tabata T; Yoshida T; Mori H; Nishida K; Yamaguchi Y; Ichida F; Fukurotani K; Inoue H; Nishida N
    J Mol Cell Cardiol; 2014 Jul; 72():273-80. PubMed ID: 24713462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of wild-type and mutant KCNQ1/KCNE1 channels by tyrosine kinase.
    Missan S; Qi J; Crack J; McDonald TF; Linsdell P
    Pflugers Arch; 2009 Jul; 458(3):471-80. PubMed ID: 19139916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KCNE4 can co-associate with the I(Ks) (KCNQ1-KCNE1) channel complex.
    Manderfield LJ; George AL
    FEBS J; 2008 Mar; 275(6):1336-49. PubMed ID: 18279388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro molecular interactions and distribution of KCNE family with KCNQ1 in the human heart.
    Bendahhou S; Marionneau C; Haurogne K; Larroque MM; Derand R; Szuts V; Escande D; Demolombe S; Barhanin J
    Cardiovasc Res; 2005 Aug; 67(3):529-38. PubMed ID: 16039274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A general mechanism of KCNE1 modulation of KCNQ1 channels involving non-canonical VSD-PD coupling.
    Wu X; Perez ME; Noskov SY; Larsson HP
    Commun Biol; 2021 Jul; 4(1):887. PubMed ID: 34285340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.